Research & Development

• Radiomics extracts quantitative patterns, textures, and features from medical imaging that are beyond human visual detection.
• PAMLEE leverages these radiomic markers to function as a robust diagnostic support system trained on thousands of imaging datasets.
• By integrating machine learning, advanced medical imaging (MRI, CT), and predictive analytics, PAMLEE delivers actionable clinical insights.
• As precision medicine advances, radiomics is defining the future of diagnostics, with HealioScan positioned at the forefront of this evolution.

Radiomics is an emerging science that extracts quantitative data from medical imaging—patterns, textures, and features that the human eye cannot see.

PAMLEE leverages these radiomic markers to create a powerful diagnostic support system. By training on thousands of imaging datasets, PAMLEE identifies subtle differences that may indicate early signs of cancer.

This data-driven approach combines:

• Machine Learning: Algorithms trained to detect risk markers.
• Medical Imaging: MRI, CT, and other scan data.
• Predictive Analytics: Insights to guide clinical decision-making.

Radiomics represents the future of precision medicine, and HealioScan is proud to be at the forefront.